Tesamorelin and Vesilute Interaction

Synergistic
Mechanism-based 47% confidence

Tesamorelin and Vesilute have a synergistic interaction with 47% confidence. Tesamorelin and Vesilute work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Vesilute

ED Dipeptide | Bladder & Urinary Tract Bioregulator

Vesilute acts on the smooth muscle cells and vascular endothelium of the urogenital system. It is proposed to: (1) regulate smooth muscle contraction and relaxation in the bladder wall, (2) enhance microcirculation and blood flow in pelvic tissues including prostate, (3) support cellular regeneration and tissue repair in the urinary tract, (4) reduce hyperemia and inflammation-related dysfunction, and (5) modulate gene expression related to urogenital tissue homeostasis through bioregulation pathways characteristic of Khavinson peptides.

Half-life: Not established Typical dose: 10-20 mg per day other, longevity
carcinogenic riskteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (Tesamorelin, Vesilute). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (Tesamorelin, Vesilute). Monitor accordingly.

Frequently Asked Questions

Can I take Tesamorelin with Vesilute?

Yes, Tesamorelin and Vesilute can generally be taken together. Tesamorelin and Vesilute work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is Tesamorelin and Vesilute safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, teratogenic. Monitor accordingly.

What are the interactions between Tesamorelin and Vesilute?

Tesamorelin and Vesilute work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Tesamorelin and Vesilute?

Tesamorelin has a half-life of 26-38 minutes and Vesilute has a half-life of Not established. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Tesamorelin vs Vesilute

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.